Role of Oxidative Stress in Hypersensitivity Reactions to Sulfonamides

Antimicrobial sulfonamides are important medications. However, their use is associated with major immune-mediated drug hypersensitivity reactions with a rate that ranges from 3% to 4% in the general population. The pathophysiology of sulfa-induced drug hypersensitivity reactions is not well understo...

Full description

Saved in:
Bibliographic Details
Published inJournal of clinical pharmacology Vol. 60; no. 3; p. 409
Main Authors Elzagallaai, Abdelbaset A, Sultan, Elham A, Bend, John R, Abuzgaia, Awatif M, Loubani, Eman, Rieder, Michael J
Format Journal Article
LanguageEnglish
Published England 01.03.2020
Subjects
Online AccessGet more information
ISSN1552-4604
DOI10.1002/jcph.1535

Cover

Loading…
Abstract Antimicrobial sulfonamides are important medications. However, their use is associated with major immune-mediated drug hypersensitivity reactions with a rate that ranges from 3% to 4% in the general population. The pathophysiology of sulfa-induced drug hypersensitivity reactions is not well understood, but accumulation of reactive metabolites (sulfamethoxazole [SMX] hydroxylamine [SMX-HA] and SMX N-nitrosamine [SMX-NO]) is thought to be a major factor. These reactive metabolites contribute to the formation of reactive oxygen species (ROS) known to cause cellular damage and induce cell death through apoptosis and necroptosis. ROS can also serve as "danger signals," priming immune cells to mount an immunological reaction. We recruited 26 sulfa-hypersensitive (HS) patients, 19 healthy control subjects, and 6 sulfa-tolerant patients to this study. Peripheral blood monocytes and platelets were isolated from blood samples and analyzed for in vitro cytotoxicity, ROS and carbonyl protein formation, lipid peroxidation, and GSH (glutathione) content after challenge with SMX-HA. When challenged with SMX-HA, cells isolated from sulfa-HS patients exhibited significantly (P ≤ .05) higher cell death, ROS and carbonyl protein formation, and lipid peroxidation. In addition, there was a high correlation between cell death in PBMCs and ROS levels. There was also depletion of GSH and lower GSH/GSSG ratios in peripheral blood mononuclear cells from sulfa-HS patients. The amount of ROS formed was negatively correlated with intracellular GSH content. The data demonstrate a major role for oxidative stress in in vitro cytotoxicity of SMX reactive metabolites and indicate increased vulnerability of cells from sulfa-HS patients to the in vitro challenge.
AbstractList Antimicrobial sulfonamides are important medications. However, their use is associated with major immune-mediated drug hypersensitivity reactions with a rate that ranges from 3% to 4% in the general population. The pathophysiology of sulfa-induced drug hypersensitivity reactions is not well understood, but accumulation of reactive metabolites (sulfamethoxazole [SMX] hydroxylamine [SMX-HA] and SMX N-nitrosamine [SMX-NO]) is thought to be a major factor. These reactive metabolites contribute to the formation of reactive oxygen species (ROS) known to cause cellular damage and induce cell death through apoptosis and necroptosis. ROS can also serve as "danger signals," priming immune cells to mount an immunological reaction. We recruited 26 sulfa-hypersensitive (HS) patients, 19 healthy control subjects, and 6 sulfa-tolerant patients to this study. Peripheral blood monocytes and platelets were isolated from blood samples and analyzed for in vitro cytotoxicity, ROS and carbonyl protein formation, lipid peroxidation, and GSH (glutathione) content after challenge with SMX-HA. When challenged with SMX-HA, cells isolated from sulfa-HS patients exhibited significantly (P ≤ .05) higher cell death, ROS and carbonyl protein formation, and lipid peroxidation. In addition, there was a high correlation between cell death in PBMCs and ROS levels. There was also depletion of GSH and lower GSH/GSSG ratios in peripheral blood mononuclear cells from sulfa-HS patients. The amount of ROS formed was negatively correlated with intracellular GSH content. The data demonstrate a major role for oxidative stress in in vitro cytotoxicity of SMX reactive metabolites and indicate increased vulnerability of cells from sulfa-HS patients to the in vitro challenge.
Author Rieder, Michael J
Loubani, Eman
Abuzgaia, Awatif M
Bend, John R
Sultan, Elham A
Elzagallaai, Abdelbaset A
Author_xml – sequence: 1
  givenname: Abdelbaset A
  surname: Elzagallaai
  fullname: Elzagallaai, Abdelbaset A
  organization: Physiology and Pharmacology, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Ontario, Canada
– sequence: 2
  givenname: Elham A
  surname: Sultan
  fullname: Sultan, Elham A
  organization: Department of Paediatrics, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Ontario, Canada
– sequence: 3
  givenname: John R
  surname: Bend
  fullname: Bend, John R
  organization: Pathology and Laboratory Medicine, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Ontario, Canada
– sequence: 4
  givenname: Awatif M
  surname: Abuzgaia
  fullname: Abuzgaia, Awatif M
  organization: Department of Paediatrics, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Ontario, Canada
– sequence: 5
  givenname: Eman
  surname: Loubani
  fullname: Loubani, Eman
  organization: Department of Paediatrics, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Ontario, Canada
– sequence: 6
  givenname: Michael J
  surname: Rieder
  fullname: Rieder, Michael J
  organization: Pathology and Laboratory Medicine, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Ontario, Canada
BackLink https://www.ncbi.nlm.nih.gov/pubmed/31709574$$D View this record in MEDLINE/PubMed
BookMark eNo1j8tKAzEUQIMo9qELf0DyA1PzuplmKcW2QqHQ6rrkiSkzyTCZivP3CurqLA4cODN0nXLyCD1QsqCEsKez7T4WFDhcoSkFYJWQREzQrJQzIVQKoLdowmlNFNRiitaH3HicA95_RaeH-Onxceh9KTgmvB073xefSvwRcRjxwWs7xJwKHjI-XpqQk26j8-UO3QTdFH__xzl6X7-8rbbVbr95XT3vKiu4hCpQW2unnOZScWqIBZBCOa_pUhrtRE3BgtCCeRGI04ovgSkXQDpjjTbA5ujxt9tdTOvdqetjq_vx9D_EvgGje01C
CitedBy_id crossref_primary_10_1016_j_fct_2022_113471
crossref_primary_10_1007_s12016_023_08978_w
crossref_primary_10_1007_s11356_021_17197_9
crossref_primary_10_1016_j_jaci_2020_01_030
crossref_primary_10_1080_17512433_2023_2289543
crossref_primary_10_1111_all_15126
crossref_primary_10_18036_estubtdc_1236273
crossref_primary_10_1016_j_chemosphere_2020_128350
crossref_primary_10_1111_all_15255
crossref_primary_10_3390_antiox10020294
crossref_primary_10_1007_s11030_024_10833_9
crossref_primary_10_1093_toxsci_kfae046
crossref_primary_10_1142_S1793984421410063
crossref_primary_10_1016_j_cej_2023_147094
crossref_primary_10_3390_foods10081897
crossref_primary_10_1016_j_ijbiomac_2023_128294
crossref_primary_10_3389_fimmu_2021_653102
crossref_primary_10_1007_s40291_023_00644_3
crossref_primary_10_1016_j_ecoenv_2022_113331
crossref_primary_10_2147_DHPS_S347522
crossref_primary_10_1038_s41565_022_01071_x
crossref_primary_10_1007_s12016_021_08872_3
ContentType Journal Article
Copyright 2019, The American College of Clinical Pharmacology.
Copyright_xml – notice: 2019, The American College of Clinical Pharmacology.
DBID CGR
CUY
CVF
ECM
EIF
NPM
DOI 10.1002/jcph.1535
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
DatabaseTitleList MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1552-4604
ExternalDocumentID 31709574
Genre Journal Article
Comparative Study
GroupedDBID ---
.55
.GJ
05W
0R~
123
18M
1CY
1OB
1OC
29K
33P
34G
39C
3O-
3SF
4.4
52U
52V
53G
5RE
8-1
AAESR
AAEVG
AAHQN
AAIPD
AAMMB
AAMNL
AANHP
AANLZ
AAONW
AASGY
AAWTL
AAXRX
AAYCA
AAZKR
ABCUV
ABJNI
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCZN
ACGFO
ACGFS
ACGOF
ACIWK
ACMXC
ACPOU
ACPRK
ACRPL
ACXBN
ACXQS
ACYXJ
ADBBV
ADBTR
ADEOM
ADIZJ
ADMGS
ADNMO
ADOZA
ADSTG
ADXAS
AEFGJ
AEGXH
AEIGN
AEIMD
AENEX
AEUYR
AEYWJ
AFBPY
AFFNX
AFFPM
AFGKR
AFRAH
AFWVQ
AGHNM
AGQPQ
AGXDD
AGYGG
AHBTC
AHMBA
AI.
AIACR
AIAGR
AIDQK
AIDYY
AITYG
AIURR
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ASPBG
ATUGU
AUVAJ
AVWKF
AZFZN
AZVAB
BDRZF
BFHJK
BHBCM
BMXJE
BOGZA
BRXPI
C45
CAG
CGR
COF
CS3
CUY
CVF
D-I
DCZOG
DPXWK
DRFUL
DRMAN
DRSTM
DU5
EBD
EBS
ECM
EIF
EJD
EMOBN
F5P
FEDTE
FUBAC
G-S
GODZA
GWYGA
H13
HF~
HGLYW
HVGLF
IAO
IEA
IHR
INH
INR
IVC
KBYEO
LATKE
LEEKS
LH4
LOXES
LSO
LUTES
LW6
LYRES
MEWTI
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
MY~
N9A
NPM
O66
O9-
OVD
P2P
P2W
PALCI
PQQKQ
R.K
RIWAO
RJQFR
ROL
SAMSI
SUPJJ
SV3
TEORI
VH1
WBKPD
WH7
WIH
WIJ
WIK
WOHZO
WOIKV
WPGGZ
WXSBR
X7M
ZGI
ZXP
ZZTAW
ID FETCH-LOGICAL-c4365-f1c7ad9da36931b0c55649dea186bad4715c54a42e4f0da938529df56dbcbab52
IngestDate Mon Jul 21 06:02:44 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords in vitro diagnosis
sulfamethoxazole hydroxylamine
adverse drug reactions
drug allergy
sulfamethoxazole
idiosyncratic drug reactions
Language English
License 2019, The American College of Clinical Pharmacology.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c4365-f1c7ad9da36931b0c55649dea186bad4715c54a42e4f0da938529df56dbcbab52
PMID 31709574
ParticipantIDs pubmed_primary_31709574
PublicationCentury 2000
PublicationDate 2020-March
PublicationDateYYYYMMDD 2020-03-01
PublicationDate_xml – month: 03
  year: 2020
  text: 2020-March
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Journal of clinical pharmacology
PublicationTitleAlternate J Clin Pharmacol
PublicationYear 2020
SSID ssj0016451
Score 2.4209616
Snippet Antimicrobial sulfonamides are important medications. However, their use is associated with major immune-mediated drug hypersensitivity reactions with a rate...
SourceID pubmed
SourceType Index Database
StartPage 409
SubjectTerms Adolescent
Adult
Aged
Anti-Infective Agents - adverse effects
Anti-Infective Agents - blood
Anti-Infective Agents - metabolism
Blood Platelets - metabolism
Cell Survival - drug effects
Child
Drug Hypersensitivity - blood
Drug Hypersensitivity - etiology
Drug Tolerance
Female
Glutathione - metabolism
Healthy Volunteers
Humans
Leukocytes, Mononuclear - metabolism
Lipid Peroxidation - drug effects
Lymphocytes - metabolism
Male
Middle Aged
Oxidative Stress - drug effects
Patients
Protein Carbonylation - drug effects
Reactive Oxygen Species - metabolism
Sulfamethoxazole - adverse effects
Sulfamethoxazole - analogs & derivatives
Sulfonamides - adverse effects
Sulfonamides - blood
Sulfonamides - metabolism
Young Adult
Title Role of Oxidative Stress in Hypersensitivity Reactions to Sulfonamides
URI https://www.ncbi.nlm.nih.gov/pubmed/31709574
Volume 60
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9tAEF4FKlVcEG0p72oPKKc4tb0P4mOEglCltggSKTe0zxIUkgiMgPx6Zr1rxwoUtVwsy-v3Nx7PzM58g9Ch4dwSTnnEjyw4KITRSAolopSYVIiM6Vi54uSfv_jpgP4YsmGjMa9Xl-Syreav1pW8B1XYBri6Ktn_QLY6KWyAdcAXloAwLP8J4_OQGvj7caQ9gfeFL_1wBFbgYN7eufT00B_i3PgahoLS4eJ-bKeuF70OOYQv7dOqZnK2YLeu4u-98Vy4OXvhu1l3pSPLgh9ivoiNwiVyH13tja_ETS1oGoLZRdJONdHUlffzP8Kn7nYf4GlsCNSGkAT4n1VOVtsENcrSiHLfWLjUs75vQJAnUlOatCBIeKnMPTnstZpdtUEvs_o-gMPspkAV7B-wEn2nn7dHl3i1y6EVtAIehmuZ6uI8Yf6JU5aUPFRx-r26hzX0sTxuyQ8p7JH-BloPQOGul4pPqGEmn1HzzGP11ML9RWHdXQs38VkNxS_oxIkOnlpciQ72ooNHE7wsOrgSHZxPcV10NtHgpNc_Po1CS41IUZfPaBN1JHSmBeEZSWSsGOM000YkHS6FBkuFKUYFTQ21sRYZ6bA005ZxLZUUkqVf0epkOjHbCBvCYikz2YHvmdrMnYBqk3SoVkQyleygLf9-LmeeN-WyfHO7fx3ZQ2sLedpHHyx8qOYArL5cfisAegZrIlv5
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Role+of+Oxidative+Stress+in+Hypersensitivity+Reactions+to+Sulfonamides&rft.jtitle=Journal+of+clinical+pharmacology&rft.au=Elzagallaai%2C+Abdelbaset+A&rft.au=Sultan%2C+Elham+A&rft.au=Bend%2C+John+R&rft.au=Abuzgaia%2C+Awatif+M&rft.date=2020-03-01&rft.eissn=1552-4604&rft.volume=60&rft.issue=3&rft.spage=409&rft_id=info:doi/10.1002%2Fjcph.1535&rft_id=info%3Apmid%2F31709574&rft_id=info%3Apmid%2F31709574&rft.externalDocID=31709574